Corticotropin-releasing hormone (CRH) downregulates interleukin-18 expression in human HaCaT keratinocytes by activation of p38 mitogen-activated protein kinase (MAPK) pathway

Hyun Jeong Park, Hee Jung Kim, Jung Hoon Lee, Jun Young Lee, Baik Kee Cho, Jae Seung Kang, Hyungsik Kang, Young Yang, Dae Ho Cho

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

It is generally accepted that corticotropin-releasing hormone (CRH) acts as the main coordinator of the central response to stress. Stress or an abnormal response to stressors has been found to modify the evolution of skin disorders, including psoriasis and atopic dermatitis. Nevertheless, the specific pathogenic role of stress remains unknown in skin diseases. Interleukin (IL)-18, a member of the IL-1 family, is a key mediator of peripheral inflammation and host defense responses, and is secreted by human keratinocytes. Here, we investigated the regulatory effect of CRH on expression of IL-18 in skin keratinocytes. Exposure of HaCaT cells to CRH resulted in a reduction of IL-18 mRNA transcripts and its production was in a concentration-dependent manner. In order to investigate whether the mitogen-activated protein kinase (MAPK) signaling pathway is involved in the downregulation of IL-18 production, cells were pre-treated with SB203580, an inhibitor of p38 MAPK, prior to the addition of CRH. This pretreatment blocked the decrease in IL-18 production. In addition, CRH treatment induced rapid phosphorylation of p38 MAPK. SB203580 were able to inhibit CRH-induced p38 MAPK phosphorylation. CRH also inhibited production of IL-18 in human primary keratinocytes. These results suggest that CRH regulates IL-18 production through the MAPK signaling pathway in human keratinocytes.

Original languageEnglish
Pages (from-to)751-755
Number of pages5
JournalJournal of Investigative Dermatology
Volume124
Issue number4
DOIs
Publication statusPublished - 2005 Jan 1
Externally publishedYes

Fingerprint

Interleukin-18
Corticotropin-Releasing Hormone
p38 Mitogen-Activated Protein Kinases
Keratinocytes
Down-Regulation
Chemical activation
Skin
Phosphorylation
Mitogen-Activated Protein Kinases
Inflammation Mediators
Atopic Dermatitis
Interleukin-1
Psoriasis
Skin Diseases
Messenger RNA

Keywords

  • Corticotropin-releasing hormone (CRH)
  • Interleukin 18 (IL-18)
  • p38 mitogen-activated protein kinase (p38 MARK)

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Dermatology
  • Cell Biology

Cite this

Corticotropin-releasing hormone (CRH) downregulates interleukin-18 expression in human HaCaT keratinocytes by activation of p38 mitogen-activated protein kinase (MAPK) pathway. / Park, Hyun Jeong; Kim, Hee Jung; Lee, Jung Hoon; Lee, Jun Young; Cho, Baik Kee; Kang, Jae Seung; Kang, Hyungsik; Yang, Young; Cho, Dae Ho.

In: Journal of Investigative Dermatology, Vol. 124, No. 4, 01.01.2005, p. 751-755.

Research output: Contribution to journalArticle

Park, Hyun Jeong ; Kim, Hee Jung ; Lee, Jung Hoon ; Lee, Jun Young ; Cho, Baik Kee ; Kang, Jae Seung ; Kang, Hyungsik ; Yang, Young ; Cho, Dae Ho. / Corticotropin-releasing hormone (CRH) downregulates interleukin-18 expression in human HaCaT keratinocytes by activation of p38 mitogen-activated protein kinase (MAPK) pathway. In: Journal of Investigative Dermatology. 2005 ; Vol. 124, No. 4. pp. 751-755.
@article{a94fb88b9875450b873c17d662ac5642,
title = "Corticotropin-releasing hormone (CRH) downregulates interleukin-18 expression in human HaCaT keratinocytes by activation of p38 mitogen-activated protein kinase (MAPK) pathway",
abstract = "It is generally accepted that corticotropin-releasing hormone (CRH) acts as the main coordinator of the central response to stress. Stress or an abnormal response to stressors has been found to modify the evolution of skin disorders, including psoriasis and atopic dermatitis. Nevertheless, the specific pathogenic role of stress remains unknown in skin diseases. Interleukin (IL)-18, a member of the IL-1 family, is a key mediator of peripheral inflammation and host defense responses, and is secreted by human keratinocytes. Here, we investigated the regulatory effect of CRH on expression of IL-18 in skin keratinocytes. Exposure of HaCaT cells to CRH resulted in a reduction of IL-18 mRNA transcripts and its production was in a concentration-dependent manner. In order to investigate whether the mitogen-activated protein kinase (MAPK) signaling pathway is involved in the downregulation of IL-18 production, cells were pre-treated with SB203580, an inhibitor of p38 MAPK, prior to the addition of CRH. This pretreatment blocked the decrease in IL-18 production. In addition, CRH treatment induced rapid phosphorylation of p38 MAPK. SB203580 were able to inhibit CRH-induced p38 MAPK phosphorylation. CRH also inhibited production of IL-18 in human primary keratinocytes. These results suggest that CRH regulates IL-18 production through the MAPK signaling pathway in human keratinocytes.",
keywords = "Corticotropin-releasing hormone (CRH), Interleukin 18 (IL-18), p38 mitogen-activated protein kinase (p38 MARK)",
author = "Park, {Hyun Jeong} and Kim, {Hee Jung} and Lee, {Jung Hoon} and Lee, {Jun Young} and Cho, {Baik Kee} and Kang, {Jae Seung} and Hyungsik Kang and Young Yang and Cho, {Dae Ho}",
year = "2005",
month = "1",
day = "1",
doi = "10.1111/j.0022-202X.2005.23656.x",
language = "English",
volume = "124",
pages = "751--755",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Corticotropin-releasing hormone (CRH) downregulates interleukin-18 expression in human HaCaT keratinocytes by activation of p38 mitogen-activated protein kinase (MAPK) pathway

AU - Park, Hyun Jeong

AU - Kim, Hee Jung

AU - Lee, Jung Hoon

AU - Lee, Jun Young

AU - Cho, Baik Kee

AU - Kang, Jae Seung

AU - Kang, Hyungsik

AU - Yang, Young

AU - Cho, Dae Ho

PY - 2005/1/1

Y1 - 2005/1/1

N2 - It is generally accepted that corticotropin-releasing hormone (CRH) acts as the main coordinator of the central response to stress. Stress or an abnormal response to stressors has been found to modify the evolution of skin disorders, including psoriasis and atopic dermatitis. Nevertheless, the specific pathogenic role of stress remains unknown in skin diseases. Interleukin (IL)-18, a member of the IL-1 family, is a key mediator of peripheral inflammation and host defense responses, and is secreted by human keratinocytes. Here, we investigated the regulatory effect of CRH on expression of IL-18 in skin keratinocytes. Exposure of HaCaT cells to CRH resulted in a reduction of IL-18 mRNA transcripts and its production was in a concentration-dependent manner. In order to investigate whether the mitogen-activated protein kinase (MAPK) signaling pathway is involved in the downregulation of IL-18 production, cells were pre-treated with SB203580, an inhibitor of p38 MAPK, prior to the addition of CRH. This pretreatment blocked the decrease in IL-18 production. In addition, CRH treatment induced rapid phosphorylation of p38 MAPK. SB203580 were able to inhibit CRH-induced p38 MAPK phosphorylation. CRH also inhibited production of IL-18 in human primary keratinocytes. These results suggest that CRH regulates IL-18 production through the MAPK signaling pathway in human keratinocytes.

AB - It is generally accepted that corticotropin-releasing hormone (CRH) acts as the main coordinator of the central response to stress. Stress or an abnormal response to stressors has been found to modify the evolution of skin disorders, including psoriasis and atopic dermatitis. Nevertheless, the specific pathogenic role of stress remains unknown in skin diseases. Interleukin (IL)-18, a member of the IL-1 family, is a key mediator of peripheral inflammation and host defense responses, and is secreted by human keratinocytes. Here, we investigated the regulatory effect of CRH on expression of IL-18 in skin keratinocytes. Exposure of HaCaT cells to CRH resulted in a reduction of IL-18 mRNA transcripts and its production was in a concentration-dependent manner. In order to investigate whether the mitogen-activated protein kinase (MAPK) signaling pathway is involved in the downregulation of IL-18 production, cells were pre-treated with SB203580, an inhibitor of p38 MAPK, prior to the addition of CRH. This pretreatment blocked the decrease in IL-18 production. In addition, CRH treatment induced rapid phosphorylation of p38 MAPK. SB203580 were able to inhibit CRH-induced p38 MAPK phosphorylation. CRH also inhibited production of IL-18 in human primary keratinocytes. These results suggest that CRH regulates IL-18 production through the MAPK signaling pathway in human keratinocytes.

KW - Corticotropin-releasing hormone (CRH)

KW - Interleukin 18 (IL-18)

KW - p38 mitogen-activated protein kinase (p38 MARK)

UR - http://www.scopus.com/inward/record.url?scp=16844374322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16844374322&partnerID=8YFLogxK

U2 - 10.1111/j.0022-202X.2005.23656.x

DO - 10.1111/j.0022-202X.2005.23656.x

M3 - Article

C2 - 15816833

AN - SCOPUS:16844374322

VL - 124

SP - 751

EP - 755

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 4

ER -